Cargando…

Association between the overexpression of Her3 and clinical pathology and prognosis of colorectal cancer: A meta-analysis

BACKGROUND: This study aimed to investigate the association between the overexpression of human epidermal growth factor receptor-3 (Her3) and the clinicopathological parameters and survival of patients with colorectal cancer (CRC). METHODS: Relevant studies on the overexpression of Her3 (measured by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Qingying, Guo, Kaibo, Feng, Guan, Shan, Feiyu, Sun, Leitao, Zhang, Kai, Shen, Fengfei, Shen, Minhe, Ruan, Shanming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156033/ https://www.ncbi.nlm.nih.gov/pubmed/30212974 http://dx.doi.org/10.1097/MD.0000000000012317

Ejemplares similares

CXCR4 and CXCR3 are two distinct prognostic biomarkers in breast cancer: Database mining for CXCR family members
por: Guo, Kaibo, et al.
Publicado: (2019)

Inhibition to Epithelial-Mesenchymal Transition and Metastatic Potential In Colorectal Cancer Cell By Combination of Traditional Chinese Medicine Formulation Jiedu Sangen Decoction and PD-L1 Inhibitor
por: Shan, Feiyu, et al.
Publicado: (2020)

The Role of Combination Maintenance with Pemetrexed and Bevacizumab for Advanced Stage Nonsquamous Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Shan, Feiyu, et al.
Publicado: (2018)

Expression of Protein 4.1 Family in Breast Cancer: Database Mining for 4.1 Family Members in Malignancies
por: Feng, Guan, et al.
Publicado: (2019)

Jiedu Sangen Decoction Inhibits the Invasion and Metastasis of Colorectal Cancer Cells by Regulating EMT through the Hippo Signaling Pathway
por: Yuan, Li, et al.
Publicado: (2019)

Risk factors and predictors of lymph nodes metastasis and distant metastasis in newly diagnosed T1 colorectal cancer
por: Guo, Kaibo, et al.
Publicado: (2020)

The Method of Activating Blood and Dredging Collaterals for Reducing Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis
por: Li, Zhaoyi, et al.
Publicado: (2019)

Risk of Second Primary Malignancies in Colon Cancer Patients Treated With Colectomy
por: Zhang, Bo, et al.
Publicado: (2020)

Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors
por: Guo, Kaibo, et al.
Publicado: (2021)

Comparison of Immune Checkpoint Inhibitors between Older and Younger Patients with Advanced or Metastatic Lung Cancer: A Systematic Review and Meta-Analysis
por: Zhang, Leyin, et al.
Publicado: (2019)

Jiedu Sangen Decoction Inhibits Migration and Invasion of Colon Cancer SW480 Cells via Suppressing Epithelial Mesenchymal Transition
por: Zhang, Kai, et al.
Publicado: (2018)

Results from a Meta-analysis of Combination of PD-1/PD-L1 and CTLA-4 Inhibitors in Malignant Cancer Patients: Does PD-L1 Matter?
por: Feng, Yuqian, et al.
Publicado: (2021)

HIT000218960 promotes gastric cancer cell proliferation and migration through upregulation of HMGA2 expression
por: Sun, Leitao, et al.
Publicado: (2019)

The prognostic value of 4.1 mRNA expression in non-small cell lung cancer
por: Xiang, Yuying, et al.
Publicado: (2021)

Association of Survival and Immune-Related Adverse Events With Anti-PD-1/PD-L1 and Anti-CTLA-4 Inhibitors, Alone or Their Combination for the Treatment of Cancer: A Systematic Review and Meta-Analysis of 13 Clinical Trials
por: Zhang, Leyin, et al.
Publicado: (2021)

Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome
por: Tao, Fangfang, et al.
Publicado: (2017)

Clinical efficacy and safety of anti-PD-1/PD-L1 inhibitors for the treatment of advanced or metastatic cancer: a systematic review and meta-analysis
por: Sun, Leitao, et al.
Publicado: (2020)

Association Between Metabolic Syndrome and Risk of Renal Cell Cancer: A Meta-Analysis
por: Du, Wurong, et al.
Publicado: (2022)

Identification of biomarkers in colon cancer based on bioinformatic analysis
por: Zhu, Ying, et al.
Publicado: (2020)

Characteristics and differences of gut microbiota in patients with different Traditional Chinese Medicine Syndromes of Colorectal Cancer and normal population
por: Wang, Peipei, et al.
Publicado: (2020)

Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial- mesenchymal transition via the AKT/GSK-3β/Snail signaling pathway
por: Yuan, Li, et al.
Publicado: (2019)

Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial-mesenchymal transition via the AKT/GSK-3β/Snail signaling pathway
por: Yuan, Li, et al.
Publicado: (2022)

Risk factors for in-hospital mortality in patients with cancer and COVID-19
por: Guo, Kaibo, et al.
Publicado: (2020)

Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?
por: Kavanagh, Dara O, et al.
Publicado: (2009)

Fuling Granule, a Traditional Chinese Medicine Compound, Suppresses Cell Proliferation and TGFβ-Induced EMT in Ovarian Cancer
por: Tao, Fangfang, et al.
Publicado: (2016)

Causes of Death After Colorectal Cancer Diagnosis: A Population-Based Study
por: Feng, Yuqian, et al.
Publicado: (2021)

What Causes Death in Esophageal Cancer Patients Other Than the Cancer Itself: A Large Population-Based Analysis
por: Zheng, Xueer, et al.
Publicado: (2022)

Prognostic Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Patients With Early Onset Colon Adenocarcinoma
por: Jin, Huimin, et al.
Publicado: (2020)

Corrigendum: Prognostic Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Patients With Early Onset Colon Adenocarcinoma
por: Jin, Huimin, et al.
Publicado: (2021)

Compound Fuling Granule Suppresses Ovarian Cancer Development and Progression by disrupting mitochondrial function, galactose and fatty acid metabolism
por: Ruan, Shanming, et al.
Publicado: (2018)

Transcription factor POU4F2 promotes colorectal cancer cell migration and invasion through hedgehog‐mediated epithelial‐mesenchymal transition
por: Guo, Kaibo, et al.
Publicado: (2021)

Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis
por: Wu, Sheng-wen, et al.
Publicado: (2015)

HER2 Overexpression and Mismatch Repair Deficiency are Correlated with Malignancy in Colorectal Cancer
por: Luo, Hai, et al.
Publicado: (2021)

Nomograms for Predicting Specific Distant Metastatic Sites and Overall Survival of Breast Invasive Ductal Carcinoma Patients After Surgery: A Large Population-Based Study
por: Feng, Yuqian, et al.
Publicado: (2022)

A Predictive Nomogram for Early Mortality in Stage IV Gastric Cancer
por: Feng, Yuqian, et al.
Publicado: (2020)

Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer
por: Hu, Tingting, et al.
Publicado: (2015)

CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer
por: Wu, Wen-jing, et al.
Publicado: (2013)

KRAS mutation in relation to HER2 overexpression/amplification in colorectal cancer
por: Bar, Julia K, et al.
Publicado: (2012)

Cytoplasmic Overexpression of HER2: a Key Factor in Colorectal Cancer
por: Blok, Erik J, et al.
Publicado: (2013)

Prediction of clinicopathological features, multi-omics events and prognosis based on digital pathology and deep learning in HR(+)/HER2(−) breast cancer
por: Hu, Jia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3odls4h2f1jvgnaqii943en9k0